Insulin receptor-inspired soluble insulin binder

Eur J Cell Biol. 2023 Jun;102(2):151293. doi: 10.1016/j.ejcb.2023.151293. Epub 2023 Feb 3.

Abstract

The insulin receptor (IR) is a 320 kDa membrane receptor tyrosine kinase mediating the pleiotropic actions of insulin, leading to phosphorylation of several intracellular substrates including serine/threonine-protein kinase (AKT1), and IR autophosphorylation. Structural details of the IR have been recently revealed. A high-binding insulin site, L1 (Kd =2 nM), consists of two distant domains in the primary sequence of the IR. Our design simplified the L1 binding site and transformed it into a soluble insulin binder (sIB). The sIB, a 17 kDa protein, binds insulin with 38 nM affinity. The sIB competes with IR for insulin and reduces by more than 50% phosphorylation of AKT1 in HEK 293 T cells, with similar effects on IR autophosphorylation. The sIB represents a new tool for research of insulin binding and signaling properties.

Keywords: AKT; Insulin; Insulin receptor.

MeSH terms

  • HEK293 Cells
  • Humans
  • Insulin* / metabolism
  • Phosphorylation
  • Protein Serine-Threonine Kinases
  • Receptor, Insulin* / metabolism
  • Signal Transduction*

Substances

  • Insulin
  • Protein Serine-Threonine Kinases
  • Receptor, Insulin